Declaration of Competing Interest EDM reports participation in advisory boards for Amgen, Astra Zeneca, Amarin, Bayer, Boehringer Ingelheim, Esperion, Novartis, Novo Nordisk, and Pfizer
Data from a large retrospective cohort study to be presented at the 2026 American Society of Clinical Oncology (ASCO) Breakthrough Meeting showed that GLP-1 receptor agonist (GLP-1 RA) use was significantly associated with lower colorectal cancer incidence among patients with inflammatory bowel disease (IBD), including those with comorbid type 2 diabetes (T2D)
Reports of acute pancreatitis linked to GLP-1 use, though rare, led to FDA warnings recommending careful monitoring in at-risk patients and avoidance in those with previous episodes
By mimicking the actions of key hormones in the body, it offers individuals an innovative tool to manage their weight and blood sugar levels effectively
When lab work can help Lab work can help when shedding is heavy, lasts more than a couple of months, or comes with fatigue, dizziness, brittle nails, or other symptoms